The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.

Journal of Neural Transmission
Karl StreckerJohannes Schwarz

Abstract

Drug-induced dyskinesia is a major complication of dopamine replacement therapy in advanced Parkinson's disease consisting of dystonia, chorea and athetosis. Agonists at 5-HT1A-receptors attenuate levodopa-induced motor complications in non-human primates. Mice with increased dopamine D2 receptor (DRD2) signalling due to the lack of expression of the regulator of G-protein signalling 9 (RGS9) also develop dyskinesia following levodopa treatment. We investigated whether the 5-HT1A-receptor agonist flibanserin compared with buspirone reduces motor abnormalities induced by levodopa or quinelorane, a selective dopamine D2-receptor agonist. Following dopamine depletion via reserpine, 40 mice (20 wild-type and 20 RGS9 knock-out) were treated with flibanserin or buspirone in combination with levodopa or quinelorane. Motor behaviour was analysed using open field analysis. RGS9 knock-out mice displayed significantly more drug-induced dystonia (p < 0.04; t test) than wild type. In quinelorane-treated wild-type mice flibanserin as well as buspirone significantly reduced dystonia (p < 0.05). In RGS9 knock-out animals again both reduced quinelorane-induced dystonia. However, flibanserin was significantly more effective (p = 0.003). Followin...Continue Reading

References

Apr 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·B KleedorferG M Stern
Feb 1, 1994·Clinical Neuropharmacology·V BonifatiG Meco
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Sep 24, 1999·Pharmacology, Biochemistry, and Behavior·F BorsiniN Pitsikas
Mar 29, 2001·Neuroscience·A LopezJ L Labandeira-Garcia
Aug 15, 2002·CNS Drug Reviews·Franco BorsiniStephan Pollentier
Apr 1, 2003·Nature Neuroscience·Barbara PicconiPaolo Calabresi
Jun 24, 2003·Neuron·Zia RahmanEric J Nestler
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Venetia ZachariouEric J Nestler
Feb 11, 2004·The Journal of Pharmacology and Experimental Therapeutics·Patrick Osei-Owusu, Karie E Scrogin
Feb 18, 2004·Current Drug Targets. CNS and Neurological Disorders·Laurence Lanfumey, Michel Hamon
Nov 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Theresa M Cabrera-VeraHeidi E Hamm
Feb 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Abraham KovoorJohannes Schwarz
Apr 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Joseph Jankovic
May 19, 2005·Experimental Neurology·M LundbladM A Cenci
Jul 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Jonathan M Brotchie
Sep 3, 2005·Synapse·Tiziana AntonelliLuca Ferraro
Nov 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anatol C Kreitzer, Robert C Malenka
Feb 7, 2006·Brain Research Bulletin·Juliana P M V CastroVanessa C Abílio
Jun 21, 2006·Synapse·Philip SeemanTomiki Sumiyoshi
Jul 10, 2007·Current Neurology and Neuroscience Reports·Theresa A ZesiewiczRobert A Hauser
Dec 13, 2007·Brain Research·Jacqueline BlundellCraig M Powell
Dec 28, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Stephen J GoldErwan Bezard
May 14, 2008·Neurology·Heiko Braak, Kelly Del Tredici
Nov 19, 2008·Journal of Neurology·Francesca Del Sorbo, Alberto Albanese
Oct 29, 2008·The Journal of Pharmacology and Experimental Therapeutics·N P VisanjiJ M Brotchie
Feb 4, 2010·Parkinsonism & Related Disorders·Amandine Berthet, Erwan Bezard
Oct 14, 2010·BMJ : British Medical Journal·Jeanne Lenzer

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.